McConnel W R, Borzelleca J F
Arch Int Pharmacodyn Ther. 1978 Oct;235(2):180-6.
In vitro studies on rat submaxillary gland slices with 3H-delta9-THC (3.6 X 10(-6)M) showed that this drug was transported into and accumulated by salivary tissue. Approximately 50% of the delta9-THC was firmly bound in or on the tissue. The uptake of 3H-delta9-THC was unchanged from control conditions (pH 7.4, 37 degrees C, 100% oxygen, 3.2 X 10(-6)M) when the metabolic inhibitors, 2,4-dinitrophenol (10(-3)M) and cyanide (10(-3)M) were used or when oxygen was replaced by nitrogen. The efflux of 3H-delta9-THC from salivary gland slices increased following addition of an excess of unlabeled drug. These data suggest a passive transport process for the movement of delta9-THC into salivary tissue with a possible saturable binding site operating on or in the interior of the salivary cell.
对大鼠下颌下腺切片进行的体外研究表明,用3H-δ9-四氢大麻酚(3.6×10−6M)处理时,这种药物被转运至唾液组织并在其中蓄积。约50%的δ9-四氢大麻酚牢固结合于组织内或组织上。当使用代谢抑制剂2,4-二硝基苯酚(10−3M)和氰化物(10−3M),或用氮气替代氧气时,在对照条件(pH 7.4、37℃、100%氧气、3.2×10−6M)下,3H-δ9-四氢大麻酚的摄取未发生变化。加入过量未标记药物后,唾液腺切片中3H-δ9-四氢大麻酚的流出增加。这些数据表明,δ9-四氢大麻酚进入唾液组织的过程为被动转运,在唾液细胞内或细胞表面可能存在一个可饱和的结合位点。